The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Sep. 09, 2009
Applicants:

Björn Scheffler, Remagen-Oberwinter, DE;

Matthias Simon, Bonn, DE;

Oliver Brüstle, Bonn, DE;

Ulrich Johannes Herrlinger, Bonn, DE;

Martin Glas, Bonn, DE;

Inventors:

Björn Scheffler, Remagen-Oberwinter, DE;

Matthias Simon, Bonn, DE;

Oliver Brüstle, Bonn, DE;

Ulrich Johannes Herrlinger, Bonn, DE;

Martin Glas, Bonn, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C12N 5/09 (2010.01); G01N 33/50 (2006.01); C12N 5/079 (2010.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5011 (2013.01); C12N 5/0618 (2013.01); C12N 5/0622 (2013.01); C12N 5/0693 (2013.01); G01N 33/502 (2013.01); G01N 33/5017 (2013.01); G01N 33/5058 (2013.01); G01N 33/574 (2013.01); G01N 2333/705 (2013.01); G01N 2333/70596 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention relates to a tumor cell of the peripheral zone of a tumor and methods of providing such a tumor cell. Further provided is a method for identifying a molecular marker diagnostic for an infiltrative cancer, an antibody, which specifically binds to such molecular marker, a method for identifying a therapeutic compound effective against a metastatic/infiltrative cancer disease and the use of a tumor cell according to the invention.


Find Patent Forward Citations

Loading…